Breaking News

US COVID-19 Vaccine: Each Person Has To Get 2 Injections For $74


The vaccine of Moderna Biotechnology Company in the US requires each person to have 2 injections, the final figure is $74.

Moderna Biotechnology Company on August 7, 2020 announced that each dose of COVID-19 vaccine it is developing, denoted by mRNA-1273, will cost 37 USD/dose.

Moderna is currently the leader in the COVID-19 vaccine research race in the US. They brought their vaccine mRNA-1273 into phase III of the human clinical trial, and also the last stage before a vaccine was licensed.

With that advantage, the Massachusetts-based biotechnology company has priced its vaccine three times higher than the general ground that competitors are aiming for.

The vaccine injects cancer into the body and human cells with the genetic code of the target virus. In the case of mRNA-1273, the scientists packed the mRNA fragments of SARS-CoV-2 into fat molecules at the nanoscale.

These molecules are then injected into the body, where human cells translate the mRNA to synthesize viral proteins. The viral protein is not a complete virus, so when it appears in the human body, it cannot cause disease.

But these proteins can still activate the immune system, creating antibodies to fight them. Once the immune system has been trained with these proteins, they will recognize SARS-CoV-2 and attack the virus when they conduct an invasion of the human body through the lungs.

However, on August 6, 2020, the World Health Organization (WHO) said that the potential vaccine entered the final stage of human testing does not mean it is almost ready to be widely deployed to the public.

"Phase 3 does not mean the vaccine is nearing completion, it does mean it is the first time the vaccine has been introduced into the healthy community to see if the vaccine protects them from infection."

Said the director running WHO's emergency health program, Mike Ryan.

Moderna Company has calculated all the risks into the price of the mRNA-1273 vaccine and it will charge between 32 and 37 USD per dose of vaccine as early as this trial.

This is two times higher than the US pharmaceutical giant Pfizer, which is also researching COVID-19 vaccine. When the vaccine is successfully tested, it will sell for just $19.5 per dose.

In the UK, the alliance of Sanofi and GlaxoSmithKline is also developing COVID-19 vaccines, priced at nearly $11 per dose.


No comments